MAPK3 and cervical carcinoma: In 2012, Qin et al. reported that miR-133b expression in CIN 2, 3 and cervical carcinoma had a gradual raise, which increased AKT and MAPKs (ERK1 and ERK2) phosphorylation augmenting tumorigenesis [56].